4974

Takara Bio
4974

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
¥96.81B
EV
¥68.71B
Shares Outstanding
120.42M
Beta
0.34

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
¥1170.00
P/E 2026E
39.20x
P/Revenue 2026E
1.94x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Takara Bio Inc.

gainify
4974

Takara Bio Inc.

4974

Takara Bio Inc., together with its subsidiaries, engages in bioindustry, contract development and manufacturing organization (CDMO), and gene therapy businesses in Japan, China, rest of Asia, the United States, Europe, and internationally. The company sells reagents a...

Sector

Healthcare

Industry

Biotechnology

CEO

Nakao, Koichi

Employees

1,779

IPO Date

2004-12-07

Headquarters

7-4-38 Nojihigashi, Kusatsu, Shiga, 525-0058, Japan

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

COMPANY

Pricing

Dashboard

About Us

Contact Us

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.